Location History:
- Mishima-gun, JP (2013)
- Osaka, JP (2018)
Company Filing History:
Years Active: 2013-2018
Title: Soichi Kawaharada: Innovator in Pharmaceutical Compounds
Introduction
Soichi Kawaharada is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors and promote nerve regeneration. With a total of 2 patents, his work is paving the way for advancements in the treatment of neurodegenerative diseases.
Latest Patents
Kawaharada's latest patents include innovative compounds that have potential therapeutic applications. One of his notable inventions is related to fused imidazole compounds. This invention provides compounds represented by a specific formula, which have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAα5). These compounds act as GABAα5 negative allosteric modulators, making them useful in the prevention and treatment of diseases related to GABAα5, such as Alzheimer's disease.
Another significant patent focuses on nerve regeneration promoters. This invention comprises a compound represented by a specific formula that suppresses nerve cell death. It serves as a substance for accelerating the growth and differentiation of various stem cells, including nerve stem cells and embryonic stem cells. The compound also acts as a neurodegenerative suppressor, facilitating the repair and regeneration of nerve tissues, which is crucial for the treatment of neurodegenerative diseases.
Career Highlights
Soichi Kawaharada is associated with Ono Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a strong focus on developing compounds that address critical health issues, particularly those related to nerve regeneration and neurodegenerative diseases.
Collaborations
Kawaharada has collaborated with notable colleagues, including Tetsuji Saito and Masato Higashino. These collaborations have further enhanced the research and development of his innovative compounds.
Conclusion
Soichi Kawaharada's contributions to the field of pharmaceuticals are noteworthy, particularly in the areas of neurodegenerative disease treatment and nerve regeneration. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.